EXpanding Treatment for Existing Neurological Disease (EXTEND): An Open-Label Phase II Clinical Trial of Hydroxyurea Treatment in Sickle Cell Anemia

BACKGROUND: Cerebral vasculopathy in sickle cell anemia (SCA) begins in childhood and features intracranial arterial stenosis with high risk of ischemic stroke. Stroke risk can be reduced by transcranial doppler (TCD) screening and chronic transfusion therapy; however, this approach is impractical i...

Descripción completa

Detalles Bibliográficos
Autores principales: Rankine-Mullings, Angela E, Little, Courtney R, Reid, Marvin E, Soares, Deanne P, Taylor-Bryan, Carolyn, Knight-Madden, Jennifer M, Stuber, Susan E, Badaloo, Asha V, Aldred, Karen, Wisdom-Phipps, Margaret E, Latham, Teresa, Ware, Russell E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2016
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037317/
https://www.ncbi.nlm.nih.gov/pubmed/27619954
http://dx.doi.org/10.2196/resprot.5872

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037317/
https://www.ncbi.nlm.nih.gov/pubmed/27619954
http://dx.doi.org/10.2196/resprot.5872

Ejemplares similares